Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-716-0 | CAS number: 98-95-3
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards, documentation restricted and acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 978
- Report date:
- 1978
Materials and methods
- Principles of method if other than guideline:
- 10 male Wistar rats/group; 0.3, 0.4, 0.5, 0.6 and 0.7 ml/kg; p.a. observation period 14 days
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Nitrobenzene
- EC Number:
- 202-716-0
- EC Name:
- Nitrobenzene
- Cas Number:
- 98-95-3
- Molecular formula:
- C6H5NO2
- IUPAC Name:
- nitrobenzene
- Details on test material:
- - Name of test material (as cited in study report): nitrobenzene
- Analytical purity: 99.9%
- Impurities (identity and concentrations): dinitrobenzene (< 0.07%), benzen (< 0.01%), water (< 0.01%), nitrophenole (< 3ppm), sulfur (> 1 ppm), hydrocarbons (> 10 ppm), nitrotoluene ( > 20 ppm)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Doses:
- 0.3, 0.4, 0.5, 0.6 and 0.7 mL/kg (equivalent to 360, 480, 600, 720 and 840 mg/kg bw)
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Statistics:
- Chi-square test with 95% confidence limits.
Results and discussion
Effect levels
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 588 mg/kg bw
- 95% CL:
- 480 - 648
Any other information on results incl. tables
A dose of 360 mg/kg did not cause mortalities, but all of the animals demonstrated clinical signs. These clinical signs included cyanosis (all dose groups), perturbance of equilibrium, piloerection, sedation 600 – 840 mg/kg bw), bloody eyes and poor reflexes. In animals receiving up to 480 mg/kg bw, clinical signs occurred 1 h after administration whereas in all other dose groups they occurred alreade after 15 min. 2/10 rats died after administration of 480 mg/kg, 5/10 rats after 600 mg/kg, 8/10 rats after 720 mg/kg and all 10 rats after 840 mg/kg. Mortalities occurred on days 2 to 4. Information on necropsy is not given.
Applicant's summary and conclusion
- Interpretation of results:
- harmful
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
